ORCID Profile
0000-0002-4350-5856
Current Organisations
University of Antwerp
,
University of Toronto
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: BMJ
Date: 14-03-2008
Abstract: To assess possible ergogenic properties of corticosteroid administration. A balanced, double-blind, placebo-controlled design was used. 28 well-trained cyclists and rowers. 4 weeks' daily inhalation of 800 microg budesonide or placebo. The subjects performed three incremental cycle ergometer tests until exhaustion, before and after 2 and 4 weeks of placebo or budesonide administration, to measure maximal power output (W(max)). Once a week they filled in a profile of mood state (POMS) questionnaire. There was no significant difference in W(max) between the placebo (376 (SD 25) W) and the corticosteroid group (375 (36) W) during the preintervention test, and there were no significant changes in either group after 2 and 4 weeks of intervention. No effect of the intervention on mood state was found. 4 weeks of corticosteroid or placebo inhalation in healthy, well-trained athletes did not affect maximal power output or mood state. Hence no ergogenic properties of 4 weeks' corticosteroid administration could be demonstrated, which corroborates previous studies of short-term corticosteroid administration.
Publisher: Routledge
Date: 11-09-2008
Publisher: CMA Joule Inc.
Date: 06-2020
DOI: 10.1503/CJS.005919
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 02-2006
Publisher: MDPI AG
Date: 09-02-2021
Abstract: Recent Advancements in Hematology: Knowledge, Methods and Dissemination is a series of commentary article which is published on a biannual basis by the editorial board of the journal Hemato [...]
No related grants have been discovered for Eric van Breda.